Lead magnet · Evaluation
12 questions to ask before buying any AI tool in cardiology
A practical checklist for leaders evaluating cardiovascular AI tools — built to surface the questions vendors rarely volunteer.
Download the PDFInsights
Insights on AI governance, validation, and adoption in cardiovascular care.
AI in healthcare is not just a technology decision. It is a governance, workflow, risk, and operational trust decision.
02
Governance
Governance before scale: what cardiovascular leaders should put in place first
The oversight structures, intake pathways, and accountability models that should exist before any AI tool is deployed widely.
Coming soon03
Validation
Validation vs. hype: how to evaluate AI tools in real clinical settings
Why marketing performance numbers rarely survive contact with local workflow — and how to design validation that actually matters.
Coming soon04
Implementation
Why implementation fails after the pilot
Most cardiovascular AI failures aren't model failures. They're workflow, training, and change-management failures.
Coming soon05
Monitoring
Monitoring and oversight after deployment
What ongoing review of a deployed AI tool should look like — drift, fairness, safety signals, and governance continuity.
Coming soon06
Regulation
FDA authorization is not the same as local readiness
Authorization tells you a tool exists. Readiness tells you whether your organization can responsibly deploy it.
Coming soonStay close to the work
Want this thinking applied to your organization?
The Readiness Assessment is the most direct way to translate these frameworks into a roadmap your leadership team can act on.